Abiomed (NSDQ:ABMD) shares are up 10% in morning trading today after the company posted Street-beating Q1 results and announced the acquisition of Breethe and its potential coronavirus-fighting tech.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,